Kozak & Associates’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384 Sell
32
-101
-76% -$1.26K ﹤0.01% 405
2026
Q1
$1.74K Hold
133
﹤0.01% 372
2025
Q4
$3.62K Hold
133
﹤0.01% 332
2025
Q3
$3.21K Buy
133
+40
+43% +$1.37K ﹤0.01% 354
2025
Q2
$3.98K Hold
93
﹤0.01% 308
2025
Q1
$2.78K Buy
93
+7
+8% +$262 ﹤0.01% 336
2024
Q4
$3.2K Hold
86
﹤0.01% 329
2024
Q3
$2.15K Hold
86
﹤0.01% 330
2024
Q2
$2.29K Hold
86
﹤0.01% 313
2024
Q1
$2.35K Sell
86
-3
-3% -$64 ﹤0.01% 319
2023
Q4
$1.86K Sell
89
-11
-11% -$188 ﹤0.01% 320
2023
Q3
$1.55K Sell
100
-90
-47% -$1.33K ﹤0.01% 345
2023
Q2
$2.52K Hold
190
﹤0.01% 295
2023
Q1
$2.8K Hold
190
﹤0.01% 289
2022
Q4
$2K Sell
190
-4
-2% -$40 ﹤0.01% 306
2022
Q3
$2K Hold
194
﹤0.01% 300
2022
Q2
$2K Sell
194
-6
-3% -$70 ﹤0.01% 337
2022
Q1
$2K Hold
200
﹤0.01% 350
2021
Q4
$2K Buy
+200
New +$4.32K ﹤0.01% 350

Other funds holding KD

Kozak & Associates's KD Position: Q2 2026 in Review

Kozak & Associates reduced its Kyndryl (KD) stake by 76% in Q2 2026, selling an estimated $1.26K and leaving 32 shares worth $384. The position accounts for ﹤0.01% of the portfolio, ranked #405.

Kozak & Associates first reported a position in KD in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.98K in Q2 2025. 671 funds tracked by Wall St. Rank hold KD as of Q2 2026.

  • Kozak & Associates held 32 shares of Kyndryl worth $384 as of Q2 2026.
  • Kozak & Associates sold 101 Kyndryl shares in Q2 2026, an estimated $1.26K.
  • Kyndryl made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #405 holding.
  • Kozak & Associates first reported a position in Kyndryl in Q4 2021 and has held it in 19 quarters since.
  • Kozak & Associates's Kyndryl position peaked at $3.98K in Q2 2025.
  • 671 funds tracked by Wall St. Rank held Kyndryl as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.